Brenmiller Energy Ltd.

Brenmiller Energy Ltd. announced an investment arrangement with existing investor Alpha Capital Anstalt, providing up to $2.5 million in additional capital to advance its BNRG360 growth strategy. The immediate investment of $1.5 million is through convertible preferred shares and warrants, with an initial conversion price of $1.67 per share, potentially increasing to $2.00 subject to shareholder approval. An additional $1.0 million may be raised through warrant exercises, also contingent on shareholder approval and specific pricing conditions. The funds will support the company's commercial thermal energy storage (TES) projects and expansion of its integrated clean energy solutions platform.

Brenmiller Energy Ltd. has amended its Sales Agreement with A.G.P./Alliance Global Partners to extend its termination date. This amendment is made in anticipation of the expiration of the company's current shelf registration statement on Form F-3 and the subsequent filing of a replacement statement. The extension ensures the continuity of the "at-the-market" offering program.

Brenmiller Energy Ltd. completed its sixth subsequent funding round, securing an additional $1 million from Alpha Capital Anstalt. This funding involved the issuance of 1,000 preferred shares convertible at $1.67 per share and ordinary warrants to purchase 598,802 ordinary shares at an exercise price of $14.56. The net proceeds will be used for general corporate purposes, working capital, and advancing commercial TES projects across Europe, the U.S., and the Middle East. The conversion price of previously issued preferred shares was also adjusted to $1.67 due to anti-dilution provisions.

Brenmiller Energy Ltd. (BNRG) announced the closing of a $1,000,000 Fifth Subsequent Funding with Alpha Capital Anstalt. The company issued 1,000 preferred shares, convertible at $3.39 per share, and ordinary warrants to purchase 68,681 ordinary shares at an exercise price of $14.56 per share. Proceeds will fund general corporate purposes, working capital, and commercial TES projects in Europe, the U.S., and the Middle East. This funding also triggered an anti-dilution adjustment, setting the conversion price of all previously issued preferred shares to $3.39.